Observational studyMedicine2016

The cross-reactivity of binding antibodies with different interferon beta formulations used as disease-modifying drugs in multiple sclerosis patients.

Agnieszka Wencel-Warot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.